HS
AGN

HighVista Strategies’s Allergan plc AGN Stock Holding History

HighVista Strategies’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-109,200
Closed -$19.3M – 118
2020
Q1 		$19.3M Buy
109,200
+91,400
+513% +$17.2M 17.91% 2
2019
Q4 		$3.4M Sell
17,800
-18,433
-51% -$3.33M 2.58% 10
2019
Q3 		$6.1M Buy
36,233
+17,800
+97% +$2.9M 4.16% 3
2019
Q2 		$3.09M Buy
+18,433
New +$2.55M 1.58% 12
2017
Q1 		– Sell
-26,700
Closed -$5.61M – 194
2016
Q4 		$5.61M Buy
+26,700
New +$5.53M 1.1% 23
2016
Q2 		– Sell
-53,362
Closed -$14.3M – 213
2016
Q1 		$14.3M Hold
53,362
– – 2.68% 8
2015
Q4 		$16.7M Buy
+53,362
New +$15.9M 3.1% 7

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

HighVista Strategies's AGN Position: Q2 2020 in Review

HighVista Strategies sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 109,200 shares — an estimated $19.3M sold.

HighVista Strategies first reported a position in AGN in Q4 2015 and held it in 7 quarters. The position peaked at $19.3M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • HighVista Strategies reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • HighVista Strategies sold 109,200 Allergan plc shares in Q2 2020, an estimated $19.3M.
  • HighVista Strategies first reported a position in Allergan plc in Q4 2015 and held it in 7 quarters.
  • HighVista Strategies's Allergan plc position peaked at $19.3M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on HighVista Strategies's 13F filing for Q2 2020, filed 14 Aug 2020.